Effects of prepartum somatotropin and monensin on metabolism and production of periparturient Holstein dairy cows

Fifty-five multiparous Holstein dairy cows were used to evaluate the singular and combined effects of somatotropin and monensin treatments during the late dry period on postpartum metabolism and production. Treatments were 1) control (C); 2) injection of exogenous bovine somatotropin (bST); 3) TMR top dressed with 300 mg of monensin/day (M); and 4) monensin and somatotropin in combination (bST+M) during the last 28 days before expected parturition. A 500-mg subcutaneous injection of sustained release somatotropin was administered adjacent to the tail head at d -28 and -14 relative to expected calving. Diet and management were the same for all cows after parturition. Production and intake were measured daily until 63 d in milk. Milk composition, blood metabolites, and body weight and condition score were measured weekly. Prepartum glucose, nonesterified fatty acid, and blood urea nitrogen concentrations were not different among treatments. Cows on the M treatment tended to have greater dry matter intake postpartum than those on the C treatment and 30% lower plasma nonesterified fatty acid concentrations during wk 1 postpartum than all other treatments. Milk yield and milk fat yield were not different among treatments, but milk fat percent tended to be lower for the bST+M treatment than the C treatment. Changes in plasma amino acid concentrations were consistent with mobilization of skeletal muscle protein, possibly for use in gluconeogenesis. Results from this study provide evidence that prepartum feeding of monensin reduced plasma nonesterified fatty acid concentrations and may improve glucose metabolism of the periparturient dairy cow.     

Effect of protein level in prepartum diets on metabolism and performance of dairy cows

Multigravid Holstein cows (n = 75) were used in a randomized block design to evaluate the effect of prepartum diets formulated to supply surplus energy and incremental concentrations of protein on the nutritional status of dairy cows at parturition. Cows were blocked according to expected calving date and assigned to one of five diets: 9.7, 11.7, 13.7, 14.7, and 16.2% crude protein (CP). Dietary treatments were initiated 28 d before expected calving date and fed until parturition. A common diet was fed postpartum. Dry matter intake and milk yield were recorded daily through 90 d postpartum. Increasing the protein concentration from 9.7 to 14.7% of dry matter during the last 28 d of gestation improved responses of cows during lactation. Increasing dietary protein up to 14.7% also increased milk yield response to recombinant bovine somatotropin (rbST) during the ninth week of lactation and yields of 305-d 2x mature equivalent milk, milk protein, and milk fat. Plasma aspartate aminotransferase tended to be highest in cows fed 13.7 and 14.7% CP prepartum, but decreased linearly postpartum in response to dietary protein levels. There were no treatment differences for plasma insulin-like growth factor-1 (IGF-1) at d 60 postpartum (before rbST provision), but IGF-1 on d 90 (after rbST provision) was higher in plasma of cows fed 14.7% CP than the other diets except 13.7% CP. Close-up diets containing 13.7% CP and surplus energy produced the most beneficial outcomes during the subsequent lactation.     

Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.     

Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.     

Periparturient responses of multiparous Holstein cows fed different dietary phosphorus concentrations prepartum

Our objective was to compare the effects of different prepartum dietary phosphorus concentrations on periparturient metabolism and performance. Forty-two late pregnant multiparous Holstein cows were fed 0.21, 0.31, or 0.44% P (dry basis) for 4 wk before expected calving. After parturition, all cows were fed a common lactation diet (0.40% P). In the prepartum period, cows fed 0.21% P had lower blood serum P concentrations compared with cows fed 0.31 or 0.44% P. However, serum P concentrations of all cows were within the normal range (4 to 8 mg/dL) until the day of calving when average concentrations dropped below 4 mg/dL. From 3 to 14 d postpartum, serum P of cows fed 0.21% P was greater than that of cows fed 0.31 or 0.44% P. No cows presented with or were treated for clinical hypophosphatemia in the periparturient period. Total serum Ca was lower before calving through 2 d postpartum for cows fed 0.44% P compared with those fed 0.21 or 0.31%. Prepartum dietary P treatments did not alter blood osteocalcin, hydroxyproline, and deoxypyridinoline, indicators of bone metabolism, or concentrations of parathyroid hormone or 1,25-dihydroxyvitamin D₃. Energy-corrected milk yield and milk composition (first 28 d of lactation) were not affected by prepartum dietary P concentrations. It is concluded that feeding 0.21% P (34 g of P/cow daily) prepartum is adequate for periparturient multiparous Holstein cows with high metabolic demands and genetic potential for milk production. No adverse effects on periparturient health, dry matter intake, or 28-d lactation performance resulted.     

Decreased plasma retinol, alpha-tocopherol, and zinc concentration during the periparturient period: effect of milk fever

Retinol (vitamin A), alpha-tocopherol (vitamin E), and Zn are micronutrients essential for health and performance. We determined the effects of parturition, lactation, and periparturient Ca status on plasma retinol, alpha-tocopherol, and Zn in 18 Jersey cows during the 2 wk before and after parturition. Six cows developed clinical milk fever. Prepartum plasma concentrations of retinol, alpha-tocopherol, and Zn decreased progressively in all animals. A nadir was reached at 1 d postpartum when concentrations declined to 38, 47, and 67%, respectively, of prepartal baseline concentrations. Plasma Zn returned to baseline concentrations within 3 d of calving, and plasma alpha-tocopherol returned toward baseline about 10 d after calving. Plasma retinol remained below baseline concentrations throughout the first 2 wk of lactation. The decline in plasma Zn observed at calving was more severe in cows with milk fever (parturient paresis) than in cows without milk fever. The decrease in plasma retinol and alpha-tocopherol observed at parturition was similar in cows with or without milk fever. These data document an acute decline in plasma retinol, alpha-tocopherol, and Zn in the immediate periparturient period and indicate that the decline in plasma Zn is more severe in cows with milk fever.     

Postparturient metabolic and production responses in cows previously exposed to long-term treatment with somatotropin.

Postparturient metabolic and production responses were studied for 85 multiparous cows consisting of controls and animals that had been previously exposed to long-term treatment with bST. Older cows previously exposed to bST at high doses (51.6 mg/d) had lower milk yields than controls. However, there were no significant differences compared with controls in milk yield for lower dose (17.2 mg/d) older cows or parity 2 cow groups. The bST-treated groups had higher postpartum DMI, lower serum FFA, lower serum beta-hydroxybutyrate levels, and higher serum glucose than controls. Some bST-exposed groups had lower milk fat but higher milk protein levels. All bST-treated groups had significantly lower ratios of C18 to C4 to 10 milk fatty acids. Control cows of both parity groups were in higher body condition and weighed more than bST-treated cows prior to calving. The differences in postpartum metabolism may be attributed to differences in body composition resulting from bST treatment in the prior lactation, because use of body condition score prior to calving as a covariate did not substantially alter responses. The control cows probably had greater reserves of mobilizable lipid. These contentions are supported by changes in milk composition for bST-treated cows, which were consistent with animals of greater appetite, mobilizing less lipid. The bST-treated cows were probably more energetically efficient milk producers because they produced milk from feed rather than from mobilization of tissue stores. These data suggest that bST use in a prior lactation may have potential benefit in reducing risk of metabolic disorders associated with lipid mobilization in the postparturient period.     

Effects of diet and injection of bovine somatotropin on prepubertal growth and first-lactation milk yields of Holstein cows

To determine effects of rapid prepubertal growth on first-lactation milk production, Holstein heifers were randomly assigned to one of three treatments. Thirty-five heifers were fed a standard diet to meet NRC recommendations and produce 0.8 kg of body weight (BW) gain/d (standard). Thirty-five heifers were fed a diet with higher energy (2.8 Mcal of metabolizable energy/kg) and protein (19.7% crude protein; high diet) to produce 1.2 kg of BW gain/d (high). Thirty-five heifers were fed the high diet and injected daily with bovine somatotropin (bST) (25 microg/kg of BW; high-bST). Diets were fed and bST was injected from 135 kg of BW until pregnancy was confirmed. Heifers were inseminated after BW exceeded 363 kg. Pregnant heifers were commingled and fed similar diets through gestation, parturition, and lactation. High and high-bST heifers had greater prebreeding average BW gains than standard heifers. Conversely, standard heifers had a greater average BW gain during gestation than high and high-bST heifers. High and high-bST heifers were approximately 90 d younger than standard heifers at first insemination and first parturition. Postpartum BW, body condition scores, and withers heights at parturition, and calving ease scores were not different among treatments. Standard heifers produced 14% more milk than high heifers but not more than high-bST heifers. The high-protein, high-energy diet decreased age at first parturition and first-lactation milk production, but did not affect reproduction. Injection of bST during the prepubertal growth period combined with the high diet decreased age at first parturition without reducing milk production.     

Effect of dietary energy and previous bovine somatotropin on milk yield, mastitis, and reproduction in dairy cows.

Thirty multiparous lactating Holstein cows were blocked according to time of calving and assigned to a 2 x 3 factorial arrangement of treatments in a randomized complete block design to evaluate the effects of two dietary energy concentrations either without or with bST (20.6 mg/d per cow) administered to cows that had not or had received bST during the preceding lactation. Subcutaneous injection of bST began 28 to 35 d postpartum and continued for 39 wk. The dietary energy concentration x bST interaction was not significant for any response variable. Compared with DMI of control cows, DMI was higher for cows receiving bST, being 1.6 and 2.4 kg/d higher for cows receiving bST for one and two lactations, respectively. Milk, fat, and protein yields were higher for cows receiving bST than for controls. Those receiving bST for a second lactation also produced more milk than controls until wk 20; thereafter, milk yields were similar to those of controls. Somatotropin administration had no adverse effect on udder health. Cows receiving bST tended to ovulate less regularly than controls, which may be attributed to their higher milk yield. However, BW gains during lactation were similar for all treatments, indicating that bST-treated cows built energy reserves for the subsequent lactation. Although energy concentrations of the diets had no significant impact on yield, the higher energy diet tended to depress milk fat concentration. Administration of bST to dairy cows for a second, consecutive lactation yielded responses similar for the first 20 wk of the study to those receiving bST for the first time. However, after wk 20, milk yield was less than that by cows receiving bST for the first lactation but similar to that of control cows.     

Metabolism and lactation performance in dairy cows fed a diet containing rumen-protected fat during the last twelve weeks of gestation

Effects of dietary fat supplementation prepartum on liver lipids and metabolism in dairy cows are contradictory. Thus, we examined in 18 German Holstein cows (half-sib; first lactation 305-d milk yield >9,000 kg) whether dietary fat:carbohydrate ratio during the last trimester of gestation affects lipid metabolism and milk yield. The diets were formulated to be isoenergetic and isonitrogenous but differed in rumen-protected fat (FD; 28 and 46.5 g/kg of dry matter during far-off and close-up dry period; mainly C16:0 and C18:1) and starch concentration [carbohydrate diet (CD); 2.3 times as much starch as FD]. Diets were given ad libitum starting 12 wk before expected parturition. After parturition all cows were fed a single lactation diet ad libitum for 14 wk. With the FD treatment, dry matter intake was depressed prepartum, milk yield during first 4 wk of lactation was lower (36.9 vs. 41.0 kg/d), and postpartum energy balance during this period was more negative. During the first 4 wk, cows in the FD group had lower lactose percentage and yield but higher milk fat, whereas milk protein and fat yield as well as energy-corrected milk did not differ. Between wk 5 and 14, milk fat and milk protein percentage was lower in CD than in FD. Milk fat C14:0 was lower and C16:1 was higher in the FD group. For FD cows, plasma triacylglycerol, nonesterified fatty acids, and cholesterol concentrations were higher prepartum, whereas plasma β-hydroxybutyrate and glucose concentrations were lower. During the first 10 d after parturition, plasma triacylglycerol concentration was higher in FD, and prepartum plasma glucose and cholesterol differences persisted during the first 14 wk of lactation. Irrespective of prepartum nutrient composition, concentrations of plasma leptin and subcutaneous fat leptin mRNA decreased between −10 d to +10 d relative to parturition, and liver lipids and glycogen reached maximum and minimal values, respectively, 10 d after parturition. Acetyl-coenzyme A carboxylase α mRNA abundance in subcutaneous fat decreased between −10 d to +1 d relative to parturition by 97%, whereas it was generally much lower in the liver and remained at a low level until wk 14 of lactation. In conclusion, feeding a diet containing rumen-protected fat during late lactation and dry period until calving negatively affected dry matter intake, energy balance, and milk yield during subsequent lactation, did not change acetyl-coenzyme A carboxylase α mRNA abundance in subcutaneous fat, and was not beneficial for liver lipid accumulation.     

Responses of dairy cows in early lactation to bovine somatotropin and ruminally inert fat

Bovine somatotropin (0 or 41.2 mg/d bST) and calcium salts of long-chain fatty acids (0 or .77 kg/d Ca-LCFA) were administered to 16 Holstein cows in early lactation. Cows remained on 0 or 41.2 mg/d bST for the entire 10 wk and received 0 or .77 kg/d Ca-LCFA in one of two 5-wk periods. Production data were recorded daily, milk fatty acids, and blood metabolites were determined once each period. Treatments did not affect feed intake. Fat-corrected milk (kg/d) and percentage of milk fat for cows receiving no supplementation, fatty acids alone, bST alone, and fatty acids and bST together were 33.8, 3.2; 33.5, 3.1; 37.4, 3.4; and 40.8, 3.5. Milk fatty acids below C16 were reduced with either bST or dietary fatty acids; C16 fatty acids were lower with bST but higher with dietary fatty acids; C18:0 fatty acids were reduced with dietary fatty acids; and C18:1 fatty acids were higher with either bST or dietary fatty acids. Blood acetoacetate concentrations were higher with both bST and dietary fatty acids, beta-hydroxybutyrate was not different, and FFA and insulin concentrations increased with bST. In this experiment, the energy supplied by Ca-LCFA acids enhanced the lactogenic effect of bST.     

Short communication: Hepatic gene expression for gluconeogenic enzymes in lactating dairy cows treated with bovine somatotropin

Eight lactating Holstein dairy cows (80 d in milk) were used to examine the effects of exogenous bovine somatotropin (bST) on hepatic contents of mRNA encoding pyruvate carboxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), and microsomal triglyceride transfer protein (MTP). Concentrations of bST in plasma were higher and milk production increased 20% in bST-treated cows. Liver samples from cows treated with bST had significantly higher total lipid contents than those from control cows. Although there were small numerical tendencies, neither triglyceride concentrations in liver nor nonesterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), or glucose in plasma differed significantly between bST-treated and control cows. Short-term bST treatment had no detectable effects on contents of PC, PEPCK, and MTP mRNA in the liver. In summary, exogenous bST stimulation of milk production is not mediated through enhanced liver gluconeogenesis, but may involve partitioning of glucose and fatty acids for preferential use by the mammary gland.     

Effect of continuous milking and bovine somatotropin supplementation on mammary epithelial cell turnover

Objectives were to determine effects of continuous milking (CM) and bovine somatotropin (bST) administration on 1) mammary epithelial cell (MEC) proliferation, apoptosis, and ultrastructure during late gestation and early lactation, 2) expression of genes associated with proliferation, and apoptosis in mammary epithelial cells, and 3) milk yield and composition. Second-gestation, first dry-period cows were randomly assigned to either continuous bST throughout late gestation and early lactation (+bST; n = 4) or no bST (−bST; n = 4) administration. Within each animal, udder halves were randomly assigned to CM or a 60-d dry period (control) treatment. Daily milk yield and weekly milk composition were measured during the last 60 d of gestation in CM halves and from 1 to 30 d postpartum for both halves. Mammary biopsies were obtained at −20 ± 7, −8 ± 3, +1 ± 0, +7 ± 0, and +20 ± 0 d (mean ± standard error) relative to parturition. Prepartum half-udder milk yield was greater in +bST cows than in −bST cows (9.9 vs. 8.2 kg/d) and postpartum half-udder milk yields were dramatically reduced in CM halves compared with control halves (10.6 vs. 22.2 kg/d), regardless of bST treatment. Proliferation of MEC was reduced in CM halves at −8 d (2.7 vs. 5.4%). Apoptosis of MEC was elevated during early lactation for d +1 and +7 in control halves, but was only increased at d +1 in CM halves. Turnover of MEC was not affected by bST. Ultrastructure data indicated complete involution of the control half and lactation maintenance in CM glands (d −20). By d −8, control tissue contained alveoli in an immature secretory state, but CM tissue contained both lactating and immature alveoli. Postpartum ultrastructure parameters were similar between halves until d 20 when control tissue was composed of a homogeneous population of lactating alveoli, but CM tissue contained lactating, engorged, and resting alveoli. Expression of CCAAT/enhancer binding protein-β (CEBP-β), cyclin D1, and bcl₂ were up-regulated during late gestation, but did not differ between control and CM halves. Expression of α-lactalbumin was increased in CM halves during late gestation, but was not different in CM and control tissue after parturition. Other genes evaluated (bax, insulin-like growth factor binding protein 5, ATP-binding cassette 1, and p27) were not differentially expressed at any timepoints evaluated. Results indicate that CM reduced subsequent half-udder milk yield in primiparous cows through altered MEC turnover and secretory capacity. Negative effects of CM on the subsequent lactation were not alleviated by bST supplementation.     

Feeding 2-hydroxy-4-(methylthio)-butanoic acid to periparturient dairy cows improves milk production but not hepatic metabolism

Forty-eight Holstein cows, entering second or later lactation, were utilized to determine the effects of 2-hydroxy-4-(methylthio)-butanoic acid (HMB) on milk production, hepatic lipid metabolism, and gluconeogenesis during the periparturient period. Cows were fed one of 3 diets as TMR starting 21 d before expected calving. These diets contained 0 (the basal diet), 0.09 (+HMB), or 0.18 (++HMB)% HMB. From parturition to 84 DIM, cows were fed diets that contained 0, 0.13, or 0.20% HMB. Prepartum and postpartum dry matter intakes were similar among cows fed the basal diet, +HMB and ++HMB. There was a quadratic effect on milk yield such that cows fed +HMB had the greatest milk yield; yields of milk by cows fed the basal diet and ++HMB were similar. This led to trends for increased yields of 3.5% fat-corrected milk and total solids when cows were fed +HMB. Percentages of fat, protein, and total solids in milk were not affected by treatment. Despite differences in milk yield, calculated energy balance was not affected by treatment. Plasma concentrations of NEFA, beta-hydroxybutyrate, and glucose were not different among treatments. Liver triglyceride content was similar among treatments on d 1 postpartum and was increased for cows consuming +HMB on d 21 postpartum compared with the other dietary treatments. Capacities for metabolism of [1-14C]palmitate by liver slices in vitro were not affected by treatment; however, conversion of [1-14C]propionate to CO2 and glucose decreased as the amount of HMB consumed by cows increased on d 21 postpartum. Cows consuming +HMB had greater days to first ovulation compared with cows consuming the basal diet and ++HMB as measured by plasma progesterone concentrations. These data suggest that adding HMB to low Met diets to achieve a predicted Met supply of approximately 2.3% of metabolizable protein supply is beneficial for increasing milk production but does not appear to benefit hepatic energy metabolism during early lactation.     

Production responses to bovine somatotropin in northeast dairy herds

The commercial response to bovine somatotropin was examined in northeast dairy herds from 1990 to 1998 (4-yr preapproval and 4-yr postapproval). With DHI records and Monsanto customer files, a control group (never purchased Posilac) and a bovine somatotropin (bST) group (used on at least 50% of cows) were identified. A total of 340 herds were involved and, over the 8-yr period, there were over 80,000 cows, 200,000 lactations, and 2 million test days. Herd management comparisons demonstrated the response to bST was relatively constant each year of the postapproval period. Assuming 100% of cows were supplemented, response to bST over a 305-d lactation equaled 894 kg of milk, 27 kg of milk fat, and 31 kg of milk protein. Comparisons of lactation curves were used to identify where the bST response occurred in the lactation cycle. Analysis demonstrated the responses in milk, milk fat, and protein yield were minimal in the early phase of lactation, and then gradually increased until reaching a plateau over the last half of the lactation cycle. Persistency of lactation was also improved by bST, indicating the opportunity exists to extend lactation with combined use of bST and altered reproductive management. Average age and days in milk did not differ between control and bST herds. Thus, stayability and herd-life of animals were not altered by bST treatment. Somatic cell count (SCC) linear scores were minimally affected in herds utilizing bST and the pattern of SCC over the lactation cycle was unaffected. Overall bST improved lactation yield and persistency consistently over the 4-yr postapproval period with no effects on cow stayability and herd-life.     

Evaluation of continuous lactation and increased milking frequency on milk production and mammary cell turnover in primiparous Holstein cows

We hypothesized that early-lactation increased milking frequency, in combination with bovine somatotropin (bST), would improve milk yield in continuously milked (CM) primiparous glands through greater mammary epithelial cell (MEC) function, proliferation, and reduced apoptosis (cell turnover). Primiparous cows were randomly assigned to a 2 × 2 × 2 factorial with a split-plot design to either a continuous bST (+bST, n = 4) or no bST (−bST, n = 4) treatment throughout the study. Within each animal, udder halves were randomly assigned to either a CM or a 60-d dry period (control). During late gestation, CM glands were milked twice daily until calving or until spontaneous dry-off. At calving, cows were milked either twice or 4 times daily and udder-half milk yield was recorded until 30 d postpartum. Mammary biopsies were conducted on −19 ± 13, −8 ± 6, +2, +7, and +20 d relative to calving. Postpartum milk yield was reduced in CM udder halves. Reduced milk yield in CM half udders from cows administered bST and milked 4 times daily was 35% compared with 65% in CM half udders in cows not provided bST and milked twice daily. Proliferation of MEC tended to be greater in control vs. CM tissue at 8 ± 6 d prepartum. Mammary epithelial cell proliferation was greater during the prepartum period (d −19, −8) compared with postpartum time points (d 2, 7, 20). Apoptosis of MEC was not affected by dry period length, but was elevated during the first 7 d postpartum compared with levels measured at −19, −8, and 20 d. Bovine somatotropin did not alter MEC turnover in primiparous CM or control glands. The use of increased milking frequency and bST alleviated, but did not prevent, reductions in milk yield of CM primiparous cows.     

Effect of modified dry period lengths and bovine somatotropin on yield and composition of milk from dairy cows

Dry periods of 40 to 60 d have been an industry standard because dry periods <40 d have resulted in reduced milk yields in the subsequent lactation by 10 to 30%. However, recent research has demonstrated no production losses for cows given a 30-d dry period. The current study evaluated milk production effects of shortened or omitted dry periods for cows at mature-equivalent production >12,000 kg of milk and treated with bovine somatotropin (bST). The study used 2 commercial dairies and one university dairy and included 4 treatments. Five multiparous and 5 primiparous cows from each farm were assigned to each treatment: 1) 60-d dry period, label use of bST (60DD); 2) 30-d dry period, label use of bST (30DD); 3) continuous milking, label use of bST (CMLST); and 4) continuous milking with continuous use of bST (CMCST). Per label, bST use started at 57 to 70 d in milk and ended 14 d before drying (60DD and 30DD) or expected calving date (CMLST). In primiparous cows, average milk yields during the first 17 wk of lactation were reduced for cows on treatments 30DD, CMLST, and CMCST vs. the 60DD treatment. (38.3, 35.1, and 37.5 vs. 44.1 +/- 1.3 kg/d, respectively). For multiparous cows, respective milk yields did not differ (46.6, 43.4, 46.5, and 47.7 +/- 2.1 kg/d). Shortened or omitted dry periods may impede mammary growth in primiparous cows, resulting in reduced milk yield in the subsequent lactation. In contrast, a shortened or omitted dry period with either bST protocol did not alter production in multiparous cows treated with bST. Quality aspects of prepartum milk and colostrum require additional characterization. For multiparous cows, milk income generated for short dry periods or for continuous milking might increase their profitability. At 17 wk of the subsequent lactation, estimates of the cumulative net margins of multiparous cows on the 30DD treatment and continuous milking treatments exceeded those of cows on the 60DD treatment by 40 dollars to 60 dollars per cow.     

Peripartum performance and metabolism of dairy cows in response to prepartum energy and protein intake

Twenty-six multiparous Holstein cows were used to examine the effects of prepartum energy and protein intake on periparturient metabolism and lactation performance. Two levels of energy, 1.65 Mcal/kg of net energy for lactation (NEL) and 1.30 Mcal/kg of NEL, and two levels of protein, 17.0% CP and 12.5% CP, were tested according to a factorial arrangement in a randomized block design. Dietary treatments were fed ad libitum from 21 d before expected calving date to the day of calving. After calving, all cows were fed the same diet. Increased nutrient density did not affect prepartum feed intake, but postpartum intake was higher for cows fed the high-energy diets. Treatment had no effect on cow body weight and body condition score, however, cows fed the high-energy diets were in greater energy balance throughout the study. Milk and milk component yields were unaffected by treatment. Cows fed the high-energy diets had lower plasma nonesterified fatty acid concentrations than cows fed the low energy diets (354.3 vs. 439.9 mumol/L). Hepatic triglyceride concentrations were lower for cows on the high-energy diets than for those on the low-energy diets. Liver glycogen was unaffected by treatment. Acetyl-CoA carboxylase and fatty acid synthase abundance was significantly lower at calving than pretreatment, and higher for cows on the high-energy diets relative to those on the low-energy diets. The activity of acetyl-CoA carboxylase and lipoprotein lipase was greatly decreased with the onset of lactation. Increased protein intake prepartum resulted in elevated plasma beta-hydroxybutyrate concentrations postpartum. Prepartum plasma urea nitrogen was increased and 3-methylhistidine decreased by the high protein treatments. Overall, increased energy density of prepartum diets had beneficial effects on feed intake and lipid metabolism but did not improve lactation performance. Increasing the protein content of the prepartum diet did not appear to confer any advantages to cow productivity.     

Recombinant bovine somatotropin with lactating cows fed diets differing in energy density

Sixty-four Holstein cows (32 primiparous) were assigned randomly at parturition to one of two diets differing in forage:grain ratio and were further assigned to either control or treatment with recombinant bST. A full lactation study was conducted. Total mixed rations consisted of alfalfa silage, high moisture ear corn, soybean meal, and vitamin and mineral supplements. Percentages of forage in the diet (dry basis) for the high and medium energy diets were wk 1 to 12, 38.2 and 58.2; wk 13 to 26, 48.2 and 68.2; and wk 27 to 44, 68.2 and 88.2. Injection of a saline placebo or 20.6 mg/d per cow of bST started at wk 13 and stopped at wk 43 of lactation. Administration of bST increased 305-d milk yield by 19.9 and 18.3% for multiparous cows fed high and medium grain diets and by 13.0 and 5.9% for primiparous cows fed the same diets. Body weight gain during lactation tended to be lower for cows treated with bST, and body condition scores were significantly lower for those treated with bST and fed the medium energy diets. Daily injection of bST did not change concentrations of glucose or urea in blood or beta-hydroxybutyrate in plasma. Multiparous cows had a transitory increase in plasma FFA concentration immediately after bST treatment started. Milk composition, health, and reproductive parameters observed were not adversely affected by bST administration. Cows fed low energy diets during bST administration in the first lactation did not produce as much milk as controls when compared during the first 10 wk of their second lactation.     

Effect of somatotropin on thyroid hormones and cytokines in lactating dairy cows during ad libitum and restricted feed intake.

Twelve Holsteins in first lactation were used to investigate the relationship between energy balance and effects of bovine somatotropin (bST) on thyroid hormone metabolism and cytokine concentrations in serum. Six cows were fed for ad libitum intake and six cows were feed restricted to induce negative energy balance during two treatment periods of 6 d. During treatment periods, cows were administered vehicle or 40 mg of bST/d according to a crossover design. Between treatment periods was a 15-d recovery period, during which all cows were fed ad libitum. Cows that were fed ad libitum remained in positive energy balance during control and bST treatments, whereas cows that were fed for restricted intake were in negative energy balance during control and bST treatment periods. In both dietary groups, bST decreased energy balance. Milk production and the fat percentage of milk increased during bST treatment in both dietary groups. Fat-corrected milk yield was increased 13% by bST treatment. Serum concentrations of IGF-I did not differ between dietary groups but were greater during bST than control periods. Serum thyroxine concentration was decreased by bST treatment. Serum triiodothyronine and reverse-triiodothyronine were not altered by hormone treatment, but circulating concentrations of thyroid hormones were apparently reduced by dietary restriction. Neither hepatic nor mammary thyroxine 5'-deiodinase was affected by bST treatment. Plasma concentration of tumor necrosis factor-alpha, a potential regulator of thyroxine 5'-deiodinase, was not affected by bST treatment. Short-term treatment with bST did not influence thyroid hormone metabolism in lactating cows in positive or negative energy balance.